acebutolol and carteolol

acebutolol has been researched along with carteolol in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19903 (33.33)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's1 (11.11)24.3611
2020's2 (22.22)2.80

Authors

AuthorsStudies
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H1
Topliss, JG; Yoshida, F1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Beudin, P; Ducher, JL; Gibert, J; Kantelip, JP; Lauxerois, M; Pechadre, JC; Sabot, C; Trolese, JF1
Hatori, Y; Horii, M; Nakamura, Y; Nemoto, E; Otsuka, K; Sakai, T; Tsukiyama, H; Yamamoto, Y; Yamato, T; Yoshii, Y1
Chen, YW; Chou, AK1
Carlo, MJ; Patrick, AL1

Reviews

1 review(s) available for acebutolol and carteolol

ArticleYear
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
    Journal of medicinal chemistry, 1988, Volume: 31, Issue:11

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship

1988

Trials

1 trial(s) available for acebutolol and carteolol

ArticleYear
[Central effects of five beta-adrenergic receptor blockers in healthy volunteers: a quantitative EEG study].
    Neurophysiologie clinique = Clinical neurophysiology, 1989, Volume: 19, Issue:1

    Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Brain; Carteolol; Electroencephalography; Humans; Male; Metoprolol; Monitoring, Physiologic; Pindolol; Sotalol

1989

Other Studies

7 other study(ies) available for acebutolol and carteolol

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Possible significance of the pharmacological differentiation of beta-blocking agents in hemodynamic effects in essential hypertension.
    Japanese circulation journal, 1983, Volume: 47, Issue:3

    Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Carteolol; Hemodynamics; Humans; Hypertension; Metoprolol; Oxprenolol; Propranolol

1983
Beta-blocker carteolol and oxprenolol produce cutaneous analgesia in response to needle pinpricks in the rat.
    Neurological research, 2023, Volume: 45, Issue:4

    Topics: Acebutolol; Analgesia; Anesthetics, Local; Animals; Bupivacaine; Butoxamine; Carteolol; Dose-Response Relationship, Drug; Epinephrine; Metoprolol; Oxprenolol; Pain; Rats; Rats, Sprague-Dawley

2023
Further exploration of the collision-induced dissociation of select beta blockers: Acebutolol, atenolol, bisoprolol, carteolol, and labetalol.
    Journal of mass spectrometry : JMS, 2023, Volume: 58, Issue:12

    Topics: Acebutolol; Atenolol; Bisoprolol; Carteolol; Chromatography, Liquid; Labetalol; Tandem Mass Spectrometry

2023